A nuclear beacon of hope: an advanced, metastatic glucagonoma treated with [177Lu]Lu-DOTA-TATE
Nuclear Medicine Review · 2024
DOI: 10.5603/nmr.101985 ↗At a glance
Fallbericht in Nuclear Medicine Review, 2024. Written by Martyna Kłosińska and 4 co-authors. Institution: Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland. Major MEDLINE topics: Glucagonoma, Organometallic Compounds, Octreotide, Pancreatic Neoplasms. Cited 2 times so far (Crossref).
Abstract (original language)
Glucagonoma is a rare pancreatic neuroendocrine tumor (panNET) that can be characterized by increased secretion of glucagon and distinguishing symptoms — glucagonoma syndrome with a typical dermatosis, necrolytic migratory erythema, being its most common manifestation. While surgery and somatostatin analogs remain first-line therapeutic options in panNETs, radioligand therapy with [177Lu]Lu-DOTA-TATE is a recommended second-line palliative treatment in advanced, metastatic cases. However, its prospects and efficacy are still not vastly researched in less frequent neuroendocrine neoplasms. Here, we present an extraordinary case of a metastatic glucagonoma treated with [177Lu]Lu-DOTA-TATE used as a second-line treatment in progressive disease.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland.
- Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland. jkolodziej1@wim.mil.pl.
ORCID profiles: Martyna Kłosińska, Joanna Kołodziej, Adrianna Mróz, Weronika Mądra, Grzegorz Kamiński
Cite
APA
Kłosińska, M., Kołodziej, J., Mróz, A., Mądra, W., & Kamiński, G. (2024). A nuclear beacon of hope: an advanced, metastatic glucagonoma treated with [177Lu]Lu-DOTA-TATE. Nuclear Medicine Review. https://doi.org/10.5603/nmr.101985
Vancouver
Kłosińska M, Kołodziej J, Mróz A, Mądra W, Kamiński G. A nuclear beacon of hope: an advanced, metastatic glucagonoma treated with [177Lu]Lu-DOTA-TATE. Nuclear Medicine Review. 2024. doi:10.5603/nmr.101985
BibTeX
@article{Kosiska2024,
author = {Kłosińska, Martyna and Kołodziej, Joanna and Mróz, Adrianna and Mądra, Weronika and Kamiński, Grzegorz},
title = {A nuclear beacon of hope: an advanced, metastatic glucagonoma treated with [177Lu]Lu-DOTA-TATE},
journal = {Nuclear Medicine Review},
year = {2024},
doi = {10.5603/nmr.101985}
}
EUVIMED